Skip to main content
. 2015 Aug 14;59(9):5602–5610. doi: 10.1128/AAC.00752-15

TABLE 3.

Parameter estimates from the mathematical model from the drug combination study

Parametera Mean Median 95% CI
V1 (liters) 11.71 12.56 10.0–12.60
CL1 (liters/h) 6.21 5.98 4.84–7.80
V2 (liters) 29.12 28.22 25.91–33.09
CL2 (liters/h) 6.59 6.32 4.48–8.94
POPMAX (CFU/ml) 1 × 1010 1 × 1010 1 × 1010–1.1 × 1010
Kg-S (CFU/ml/h) 1.59 1.50 1.27–2.00
Kk-S (CFU/ml/h) 2.43 2.21 2.08–3.00
E50_1S (mg/liter) 8.33 8.32 7.30–9.35
E50_2S (mg/liter) 13.51 14.84 10.00–15.75
α_S 4.78 4.88 0.878–8.56
KgR-2 (CFU/ml/h) 0.70 0.20 0.101–1.79
KkR-2 (CFU/ml/h) 2.52 2.97 1.23–3.38
E50-2R2 (mg/liter) 34.33 28.22 22.13–52.52
α_R2 0.41 0.48 −4.84–5.49
INIT_3 (CFU/ml) 1 × 1010 1 × 1010 1 × 1010–1.1 × 1010
H1-S 12.19 11.95 10.71–13.89
H2-S 2.25 1.58 1.12–4.00
H2-R2 4.96 5.74 3.30–5.82
TLAG3 (h) 42.70 43.04 32.34–52.78
a

For parameters that include a subscript numeral (1 or 2), 1 denotes a meropenem parameter and 2 denotes a fosfomycin parameter. INIT_3 is the initial condition for the total bacterial population. TLAG3 is the lag time for the fosfomycin-resistant mutants' regrowth. E50 is the half-maximal effective concentration. α_S and α_R are the interaction parameters between the antimicrobials for the susceptible and resistant populations, respectively.